HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.

Abstract
Double transgenic mice expressing mutant amyloid precursor protein (APPswe) and mutant presenilin 1 (PS1dE9) are a model of Alzheimer-type amyloidosis and are widely used in experimental studies. In the present work, the relationships between brain and plasma amyloidpeptide (Aβ) levels and cognitive impairments were examined in male APPswe/PS1dE9 double transgenic mice at different ages. When compared with non-transgenic littermates, APPswe/PS1dE9 mice exhibited significant learning deficits from the age of 6months (M6), which were aggravated at later stages of life (M8 and M12). Sporadic brain amyloid plaques were observed in mice as early as M3 and progressively increased in number and size up to M12. A similar increase was observed in brain insoluble Aβ levels as assessed by enzyme-linked immunosorbent assay (ELISA). In particular, the levels of brain insoluble Aβ peptides rose steeply from M4 to M6. Interestingly, this pronounced amyloid deposition was accompanied by a temporary fall in the concentration of brain soluble and membrane-bound Aβ peptides at M6 that rose again at M8 and M12. The plasma levels of Aβ40 and Aβ42 decreased with advancing age up to M8, when they stabilized at M12. This decrease in plasma Aβ levels coincided with the observed increase in insoluble brain Aβ levels. These results could be useful for developing plasma Aβ levels as possible biomarkers of the cerebral amyloidosis and provide advances in the knowledge of the Aβ peptide biochemical changes that occur in the brain of Alzheimer's disease patients.
AuthorsM Izco, P Martínez, A Corrales, N Fandos, S García, D Insua, M Montañes, V Pérez-Grijalba, N Rueda, V Vidal, C Martínez-Cué, P Pesini, M Sarasa
JournalNeuroscience (Neuroscience) Vol. 263 Pg. 269-79 (Mar 28 2014) ISSN: 1873-7544 [Electronic] United States
PMID24447596 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Amyloid beta-Peptides
  • Presenilin-1
Topics
  • Age Factors
  • Alzheimer Disease (metabolism, physiopathology)
  • Amyloid beta-Peptides (blood, genetics, metabolism)
  • Animals
  • Brain (metabolism, pathology)
  • Cognition Disorders (metabolism)
  • Disease Models, Animal
  • Male
  • Maze Learning (physiology)
  • Memory Disorders (metabolism)
  • Mice
  • Mice, Transgenic
  • Presenilin-1 (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: